PROBIOTIX HEALTH LS-05 (X90) — Tangible Net Worth Ratio
PROBIOTIX HEALTH LS-05 (X90) has a Tangible Net Worth Ratio of 88.2% as of June 2025. This metric is calculated by deducting intangible assets (€211.00K) from net assets (€1.79 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of PROBIOTIX HEALTH LS-05 to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PROBIOTIX HEALTH LS-05 Tangible Net Worth Ratio (2022–2024)
This chart shows how PROBIOTIX HEALTH LS-05's Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of June 2025, the ratio stands at 88.2%, reflecting net assets of €1.79 Million with intangible assets of €211.00K EUR. For live market cap and overall valuation, see X90 market cap overview.
Annual Tangible Net Worth Ratio for PROBIOTIX HEALTH LS-05 (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for PROBIOTIX HEALTH LS-05 from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See PROBIOTIX HEALTH LS-05 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.6% | €1.92 Million | €239.00K | €2.18 Million | ▲ +7.2 pp |
| 2023 | 80.3% | €1.53 Million | €301.00K | €2.17 Million | ▼ -3.7 pp |
| 2022 | 84.1% | €1.99 Million | €317.24K | €2.34 Million | — |